Pharsight

ALLERGAN patents facing oppositions

Top patents of ALLERGAN facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3431074B1 19 Jan, 2022 Preservative free bimatoprost and timolol solutions Jul, 2031 9
EP2598118B1 05 Sep, 2018 Preservative free bimatoprost and timolol solutions NA 6
EP2637710B1 05 Apr, 2017 Hyaluronic acid based formulations Nov, 2031 3
EP3256097B1 05 Jan, 2022 Compositions and methods for improving skin appearance Feb, 2036 2
EP2674147B1 01 Jan, 2020 Method of preparing a hyaluronic acid-based gel including lidocaine HCl. Mar, 2029 2
EP2598119B1 19 Sep, 2018 Preservative free brimonidine and timolol solutions Jul, 2031 2
EP2968351B1 Opioid receptor modulator dosage formulations NA 1
EP2994090B1 Hyaluronic acid gels crosslinked by sodium trimetaphosphate NA 1
EP2384210B1 Injection device NA 1
EP3520827B1 25 May, 2022 Cross-linked hydrogels for soft tissue augmentation Mar, 2031 1
EP3681500B1 23 Mar, 2022 Use of pilocarpine hydrochloride for the treatment of presbyopia Apr, 2039 1
EP3279335B1 10 Mar, 2021 Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-a NA 1
EP3169308B1 27 Jan, 2021 Suspension compositions of cyclosporin a for subconjunctival and periocular injection Jul, 2035 1
EP3138586B1 06 Jan, 2021 Soft tissue filler Nov, 2031 1
EP3003360B1 07 Oct, 2020 High potency pancreatin pharmaceutical compositions Nov, 2034 1
EP3068403B1 17 Jun, 2020 Methods of treatment of ocular conditions with a sustained drug delivery implant Nov, 2034 1
EP3187219B1 22 Apr, 2020 Injection device Dec, 2029 1
EP3256179B1 20 Nov, 2019 Implants for sculpting, augmenting or correcting facial features such as the chin NA 1
EP3432916B1 14 Aug, 2019 Stabilized non-protein clostridial toxin compositions NA 1
EP3436054B2 14 Aug, 2019 Stabilized non-protein clostridial toxin compositions NA 1
EP3024479B2 05 Jun, 2019 High potency pancreatin pharmaceutical compositions NA 1
EP3166652B1 03 Apr, 2019 Hyaluronic acid gels crosslinked by sodium trimetaphosphate NA 1
EP2922532B1 06 Mar, 2019 5-aminosalicylic acid capsule formulation Nov, 2033 1
EP2437762B1 09 Aug, 2017 Artificial tears and therapeutic uses Jun, 2030 1